Patents by Inventor Joel Cotton

Joel Cotton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7541157
    Abstract: The invention relates to an amplification-free method of screening groups of radioactive molecules, comprising at least the following steps: (1) the group of molecules is administered to at least one animal; (2) at least one of the animals is slaughtered and the tissue distribution of the radioactivity of the molecules administered is analyzed in vivo; (3) sections of tissue or organs in which a radioactivity signal is detected are selected; (4) radioactive fractions from the sections of tissue or organs are isolated using suitable techniques such as chromatography and/or extraction techniques; and (5) the molecule(s) from the radioactive fractions obtained in step 4 are characterized using suitable analysis techniques such as chromatography and/or mass spectrometry.
    Type: Grant
    Filed: May 28, 2003
    Date of Patent: June 2, 2009
    Assignee: Commissariat a l'Energie Atomique
    Inventors: Vincent Dive, André Menez, Reto Stocklin, Bertrand Tavitian, Fabrice Beau, Bertrand Czarny, Joël Cotton
  • Publication number: 20060228296
    Abstract: The invention relates to an amplification-free method of screening groups of radioactive molecules, the products from the molecule groups obtained and the application thereof in order to identify molecules that are capable of binding selectively to a tissue or a particular organ. The inventive method can be used for the development of novel therapeutic compounds and contrast agents for medical imaging and for the screening of medicaments.
    Type: Application
    Filed: May 28, 2003
    Publication date: October 12, 2006
    Applicant: COMMISSARIAT A L'ENERGIE ATOMIQUE
    Inventors: Vincent Dive, Andre Menez, Reto Stocklin, Bertrand Tavitian, Fabrice Beau, Bertrand Czarny, Joel Cotton
  • Patent number: 7105483
    Abstract: The invention relates to the use of phosphinic pseudopeptide derivatives for production of a medicament for selectively inhibiting the active C-terminal site of angiotensin I converting enzyme. These derivatives are of formula (II): where, R1 may be a protecting group for amino functions usually used in peptide chemistry or an amino acid or a peptide protected by the above type of protecting groups, R2 and R3 correspond to a natural or unnatural amino acid side chain and R4 and R5 represent a hydrogen atom or a counterion.
    Type: Grant
    Filed: January 16, 2003
    Date of Patent: September 12, 2006
    Assignee: Commissariat a l'Energie Atomique
    Inventors: Joel Cotton, Dimitri Georgiadis, Vincent Dive
  • Publication number: 20050246908
    Abstract: This invention is used for creating straight marks along floor coverings to guarantee that they can be cut perfectly to the dimensions of the area. The template has two straight edges that function as rulers. Both of these edges are hinged and are parallel to each other. The hinges allow the tool to be adjusted to fit and mark any area. In the center, between the hinged bars, there is a pencil holding plate that holds the scribing tool. This pencil is held in place by an adjustable wing nut enabling the pencil to be manipulated as necessary. Alternatively, in the second embodiment, the center plate may include graduated holes for accepting the pencil. Finally, the entire apparatus includes rolling wheels, allowing it to easily move along edges and mark the floor coverings.
    Type: Application
    Filed: May 4, 2004
    Publication date: November 10, 2005
    Inventor: Joel Cotton
  • Publication number: 20050070505
    Abstract: The invention relates to the use of phosphinic pseudopeptide derivatives for production of a medicament for selectively inhibiting the active C-terminal site of angiotensin I converting enzyme. These derivatives are of formula (II): where, R1 may be a protecting group for amino functions usually used in peptide chemistry or an amino acid or a peptide protected by the above type of protecting groups, R2 and R3 correspond to a natural or unnatural amino acid side chain and R4 and R5 represent a hydrogen atom or a counterion. Applications: prevention and treatment of cardiovascular diseases in humans.
    Type: Application
    Filed: January 16, 2003
    Publication date: March 31, 2005
    Inventors: Joel Cotton, Dimitri Georgiadis, Vincent Dive
  • Patent number: 6482797
    Abstract: The invention relates to peptide derivatives that can be used as selective inhibitors of the N-terminal site of human angiotensin-converting enzyme. The derivatives comprise the amino acid sequence with the following formula: -Asp-Phe-&PSgr;(PO2CH2)-Ala-Xaa′-  (I) wherein: &PSgr;(PO2CH2) indicates that the peptide bond (CONH) between Phe and Ala has been replaced by the phosphonic bond PO2CH2, and Xaa′ represents an amino acid residue. They can be used in pharmaceutical formulations, particularly to protect haematopoietic strain cells of patients undergoing aggressive chemotherapy or radiotherapy treatment.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: November 19, 2002
    Assignees: Commissariat A l'Energie Atomique, Institut National de la Sante et de la Recherche Medicale Inserm
    Inventors: Vincent Dive, Joël Cotton, Philippe Cuniasse, Athanasios Yiotakis, Pierre Corvol, Annie Michaud, Marie-Thérèse Chauvet, Joël Menard, Eric Ezan